Home › Chronic Lymphocytic Leukemia › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Philadelphia, PA

Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Nagre-recruitPhase 3

Thomas Jefferson University Hospital, Philadelphia
Jefferson Torresdale Hospital, Philadelphia

Edad 65 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi ang layo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Nagre-recruitPhase 3

Thomas Jefferson University Hospital, Philadelphia
Jefferson Torresdale Hospital, Philadelphia
Asplundh Cancer Pavilion, Willow Grove · 13 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04269902

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Nagre-recruitPhase 3

Thomas Jefferson University, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06943872

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nagre-recruitPhase 3

Fox Chase Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06973187

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Nagre-recruitPhase 3

Consultants in Medical Oncology and Hematology (CMOH) ( Site 8002), Broomall · 10 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06136559

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Nagre-recruitPhase 1/2

Research Site, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06564038

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

University of Pennsylvania, Abramson Cancer Center, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Nagre-recruitPhase 4

University of Pennsylvania Hospital, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876649

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Nagre-recruitPhase 4

University of Pennsylvania Hospital, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 2, 2026 · NCT06876662

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Nagre-recruitPhase 2

Pennsylvania Oncology Hematolo /ID# 249637, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT04895436

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.